Skip to main content

Advertisement

Table 1 Ten patients diagnosed with P. vivax infection were recruited in the study from two malaria clinics in Thailand: Ubon Ratchathani and Yala

From: Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

Sample Age (years) Gender Province Days of patency Parasitaemia (parasites/200 leukocytes) Patient group
UBT3086 50 Male Ubon Ratchathani 2 220 1
UBT3087 NR NR Ubon Ratchathani 3 152 2
UBT3089 41 Male Ubon Ratchathani 2 60 2
UBT3090 14 Male Ubon Ratchathani 2 226 2
UBT3091 37 Male Ubon Ratchathani 3 383 1
YL3111 26 Female Yala 2 360 3
YL3112 45 Male Yala 2 20 3
YL3113 15 Male Yala 7 160 4
YL3114 30 Female Yala 2 40 3
YL3115 46 Female Yala 7 360 4
  1. Patients ranged between 14 and 50 years of age. Information regarding days of patency was provided by patients to medical officers during their visit
  2. NR not recorded